InsidersTradesSigma
Follow the 서린바이오 share price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares are listed on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 서린바이오 has published 1 reports. Market capitalisation: €36.6bn. The latest transaction was disclosed on 2 April 2026 (Purchase). Among the most active insiders: 강미옥. The full history is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
서린바이오 是一家在XKRX上市的医疗保健和制药公司。它专注于开发创新的生物制药解决方案。